Related Experiment Video

Updated: Aug 14, 2026

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
09:47

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique

Published on: April 26, 2015

Acute effects of adrenergic agents on post-defibrillation arrest time in a cultured heart model

V Krauthamer1, T C Smith

  • 1Food and Drug Administration, Center for Devices and Radiological Health, Office of Science and Engineering Laboratories, 12725 Twinbrook Parkway, Mail stop HFZ-130, Rockville, Maryland 20852, USA. victor.krauthamer@hhs.fda.gov

Cellular and Molecular Life Sciences : CMLS
|December 8, 2004
PubMed

Insights

Adrenergic agents and verapamil affect electrical defibrillation outcomes. Adrenergic agents (epinephrine, norepinephrine, isoproterenol) shorten cardiac arrest duration, while verapamil (a calcium channel blocker) lengthens it.

Area of Science:

  • Cardiology
  • Pharmacology
  • Cell Biology

Background:

  • Electrical defibrillation is a critical intervention for cardiac arrhythmias.
  • Understanding drug interactions with defibrillation is crucial for patient safety and treatment efficacy.
  • Adrenergic agents and calcium channel blockers are commonly used cardiovascular drugs with potential to influence cardiac electrophysiology.

Purpose of the Study:

  • To investigate the effects of acute administration of adrenergic agents and a calcium channel blocker on the outcomes of electrical defibrillation.
  • To test if epinephrine, norepinephrine, isoproterenol, and verapamil alter the duration of cardiac arrest post-defibrillation shock.
  • To examine if these drugs influence the occurrence of rhythm changes following defibrillation.

Main Methods:

  • Cultured dissociated heart cells from 10-day chicken embryos into spherical aggregates.
  • Paced cell aggregates at 0.75 V/cm above contraction threshold.
  • Applied a 1 ms biphasic defibrillator shock at 46 V/cm and recorded arrest time and rhythm changes.

Main Results:

  • Adrenergic agents (epinephrine, norepinephrine, isoproterenol) significantly shortened the duration of cardiac arrest following defibrillation.
  • The calcium channel blocker verapamil significantly lengthened the arrest time after defibrillation.
  • No significant change in double beats was observed with adrenergic agents, while verapamil decreased double beats.

Conclusions:

  • Acute administration of adrenergic agents and verapamil alters the electrophysiological response to electrical defibrillation.
  • Adrenergic agents may facilitate faster rhythm restoration post-defibrillation by shortening arrest duration.
  • Verapamil may prolong the refractory period or impair electrical excitability, leading to longer arrest times.

More Related Videos

Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest08:30

Murine Isolated Heart Model of Myocardial Stunning Associated with Cardioplegic Arrest

Published on: August 6, 2015

A Model of Long-Term Ventricular Fibrillation in Isolated Rat Hearts07:56

A Model of Long-Term Ventricular Fibrillation in Isolated Rat Hearts

Published on: February 17, 2023

Related Concept Videos

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiac Action Potential01:30

Cardiac Action Potential

Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...